University of Chicago Medical Center ( Site 1037)

Chicago, Illinois 60637

1 studies enrolling now · 1 studies all time

What they study most

Urothelial Carcinoma

Studies at this site

• A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) — Recruiting now